Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency


Creative Commons License

Farmer J., Foldvari Z., Ujhazi B., De R., Chen K., Bleesing J., ...Daha Fazla

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, cilt.7, sa.6, ss.1970-1989, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.jaip.2019.02.038
  • Dergi Adı: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1970-1989
  • Anahtar Kelimeler: Recombination activating gene (RAG), Severe combined immunodeficiency (SCID), Immune dysregulation, Autoimmune cytopenias, Hematopoietic stem cell transplantation (HSCT), SEVERE COMBINED IMMUNODEFICIENCY, RECOMBINATION ACTIVITY, GRANULOMATOUS-DISEASE, CLINICAL PHENOTYPES, VACCINE-STRAIN, OMENN SYNDROME, MUTATIONS, CYTOPENIAS, RITUXIMAB, GENE
  • Erciyes Üniversitesi Adresli: Evet

Özet

BACKGROUND: Although autoimmunity and hyperinflammation secondary to recombination activating gene (RAG) deficiency have been associated with delayed diagnosis and even death, our current understanding is limited primarily to small case series.